General Wesley Clark Joins Vaya Space as Senior Board and 14-02-2023, 20:47

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Mavenir’s AI-Driven Fraud Defense Solutions Win FutureNet Asia Award for Customer Experience Innovation 18-09-2025, 19:00